UK markets close in 6 hours 52 minutes

Nicox S.A. (0RCQ.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
1.2680-0.0436 (-3.33%)
As of 05:51PM GMT. Market open.
Full screen
Previous close1.3116
Open0.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0000 - 0.0000
52-week range
Volume132
Avg. volumeN/A
Market cap367,146
Beta (5Y monthly)1.03
PE ratio (TTM)N/A
EPS (TTM)-1.1670
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Number of voting rights as of November 30, 2022

    Nicox SASociété anonyme with a registered capital of € 50,100,448 Head Office:DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On December 1, 2022, MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS (Article L.233-8 II of the Code de Commerce and Articles 221-1 and 223-16 of the Règlement général of the l’AMF) As of November 30, 2022Total number of shares composing the share capital50,100,448T

  • Globe Newswire

    Nicox Raises €10 Million in Private Placement

    Press Release Nicox Raises €10 Million in Private Placement Net proceeds from the private placement to extend the cash runway to mid-May 2024Warrants to be issued in the private placement could provide an additional €11.6 million proceeds if they were to be fully exercised November 22, 2022 – release at 7:30 am CETSophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced a financing through a private placement via the issuance

  • Globe Newswire

    Nicox Raises €10 Million in Private Placemen

    Press Release Nicox Raises €10 Million in Private Placement Net proceeds from the private placement to extend the cash runway to mid-May 2024Warrants to be issued in the private placement could provide an additional €11.6 million proceeds if they were to be fully exercised November 22, 2022 – release at 7:30 am CETSophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced a financing through a private placement via the issuance